MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ALNY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alnylam Pharmaceuticals (ALNY) Ownership - Who owns Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2500
Web
https://www.alnylam.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
38.22B
P/E Ratio
71.93
Total Cash
3.01B
Projected Growth
0.49
Total Debt
1.27B
Revenue
4.29B
Risk (Beta)
0.98
Dividend Yield
N/A
Total Cash/Share
22.54
Total Debt/Equity
N/A
Revenue/Share
31.33 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ALNY
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for ALNY
A.I. Advisor
published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2500
Web
https://www.alnylam.com